Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management
about
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsCOTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo.Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation.Fasting protects mice from lethal DNA damage by promoting small intestinal epithelial stem cell survival.Overview of Cancer Stem Cells and Stemness for Community Oncologists.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionIs There an Opportunity for Current Chemotherapeutics to Up-regulate MIC-A/B Ligands?A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice.Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer.Breast metastasis from vaginal cancer.Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy.A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro.Effects of Oxaliplatin Treatment on the Myenteric Plexus Innervation and Glia in the Murine Distal ColonOxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon.Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host DiseaseThymineless Death by the Fluoropyrimidine Polymer F10 Involves Replication Fork Collapse and Is Enhanced by Chk1 Inhibition
P2860
Q28079705-7D3976D7-E113-4D64-B7BD-D4E7457E61FAQ30367429-2A5806B5-B895-4A49-A727-9C25512F575EQ36318355-058DD59E-26EE-494B-BFB8-7C867A510007Q36419792-C7CC15CA-43D7-48AA-A5F8-3C0AB9EDDF41Q39406329-22F36B10-A445-4AA4-BADE-977623DB1806Q42371575-C4276975-9139-4E94-8176-D0C98C22284AQ47110491-2B61023B-5CB8-42CC-9107-87F25D5C2DA5Q47129888-CBC18EE3-79D0-4782-92B6-749DD46808AEQ47408611-87B09293-4FC4-4B3F-9666-A0D21658BD36Q48148624-3602C70A-7179-4A73-85A4-5F89678577FAQ51740367-ECA1CC1C-76A7-43FB-AF8F-4120F4B864CEQ52722043-84B0968C-53FF-4830-87DE-62728E22F76FQ53058208-18C5197E-3BDA-4057-942B-00040E2CD0A8Q55198257-82709466-82A5-4069-966C-AAD2C5343293Q59130037-E974BEA0-E351-4874-B75A-71A0555187A4Q59137352-52B23976-67B1-446E-8769-08A65EE01274
P2860
Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Systemic treatment-induced gas ...... al presentation and management
@ast
Systemic treatment-induced gas ...... al presentation and management
@en
Systemic treatment-induced gas ...... al presentation and management
@nl
type
label
Systemic treatment-induced gas ...... al presentation and management
@ast
Systemic treatment-induced gas ...... al presentation and management
@en
Systemic treatment-induced gas ...... al presentation and management
@nl
prefLabel
Systemic treatment-induced gas ...... al presentation and management
@ast
Systemic treatment-induced gas ...... al presentation and management
@en
Systemic treatment-induced gas ...... al presentation and management
@nl
P2093
P2860
P3181
P1476
Systemic treatment-induced gas ...... al presentation and management
@en
P2093
Boussios S
Katsanos K
Pavlidis N
Pentheroudakis G
P2860
P304
P3181
P577
2012-01-01T00:00:00Z